Fifth Third Bancorp’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.56M | Sell |
47,486
-3,318
| -7% | -$213K | 0.01% | 979 |
|
|
2026
Q1 | $2.86M | Buy |
50,804
+50,400
| +12,475% | +$3.28M | 0.01% | 1029 |
|
|
2025
Q4 | $32.4K | Buy |
404
+161
| +66% | +$10.8K | ﹤0.01% | 1667 |
|
|
2025
Q3 | $11.8K | Sell |
243
-187
| -43% | -$11.6K | ﹤0.01% | 2089 |
|
|
2025
Q2 | $32.1K | Buy |
430
+60
| +16% | +$3.97K | ﹤0.01% | 1598 |
|
|
2025
Q1 | $23.5K | Buy |
370
+26
| +8% | +$1.77K | ﹤0.01% | 1703 |
|
|
2024
Q4 | $26.9K | Buy |
344
+75
| +28% | +$6.02K | ﹤0.01% | 1648 |
|
|
2024
Q3 | $21.6K | Sell |
269
-15
| -5% | -$1.21K | ﹤0.01% | 1760 |
|
|
2024
Q2 | $23.5K | Buy |
284
+122
| +75% | +$10.7K | ﹤0.01% | 1668 |
|
|
2024
Q1 | $13.8K | Sell |
162
-175
| -52% | -$13.7K | ﹤0.01% | 1778 |
|
|
2023
Q4 | $28.8K | Sell |
337
-56
| -14% | -$4.84K | ﹤0.01% | 1637 |
|
|
2023
Q3 | $35.2K | Sell |
393
-1,555
| -80% | -$139K | ﹤0.01% | 1505 |
|
|
2023
Q2 | $166K | Buy |
1,948
+52
| +3% | +$4.4K | ﹤0.01% | 1013 |
|
|
2023
Q1 | $157K | Buy |
1,896
+39
| +2% | +$3.16K | ﹤0.01% | 1070 |
|
|
2022
Q4 | $146K | Buy |
1,857
+27
| +1% | +$2.17K | ﹤0.01% | 1014 |
|
|
2022
Q3 | $135K | Hold |
1,830
| – | – | ﹤0.01% | 1034 |
|
|
2022
Q2 | $119K | Buy |
1,830
+30
| +2% | +$1.77K | ﹤0.01% | 1087 |
|
|
2022
Q1 | $114K | Sell |
1,800
-132
| -7% | -$7.18K | ﹤0.01% | 1153 |
|
|
2021
Q4 | $102K | Buy |
1,932
+967
| +100% | +$58.9K | ﹤0.01% | 1229 |
|
|
2021
Q3 | $68K | Sell |
965
-776
| -45% | -$49K | ﹤0.01% | 1307 |
|
|
2021
Q2 | $116K | Buy |
1,741
+1,605
| +1,180% | +$114K | ﹤0.01% | 1140 |
|
|
2021
Q1 | $15K | Buy |
+136
| New | +$16.8K | ﹤0.01% | 1876 |
|
|
2020
Q4 | – | Sell |
-48
| Closed | -$4K | – | 2391 |
|
|
2020
Q3 | $4K | Sell |
48
-3,392
| -99% | -$296K | ﹤0.01% | 1934 |
|
|
2020
Q2 | $308K | Buy |
3,440
+443
| +15% | +$44.7K | ﹤0.01% | 742 |
|
|
2020
Q1 | $299K | Buy |
2,997
+2,705
| +926% | +$293K | ﹤0.01% | 716 |
|
|
2019
Q4 | $34K | Hold |
292
| – | – | ﹤0.01% | 1512 |
|
|
2019
Q3 | $37K | Hold |
292
| – | – | ﹤0.01% | 1448 |
|
|
2019
Q2 | $35K | Sell |
292
-67
| -19% | -$6.59K | ﹤0.01% | 1481 |
|
|
2019
Q1 | $31K | Hold |
359
| – | – | ﹤0.01% | 1428 |
|
|
2018
Q4 | $36K | Sell |
359
-64
| -15% | -$6.72K | ﹤0.01% | 1343 |
|
|
2018
Q3 | $48K | Sell |
423
-56
| -12% | -$5.8K | ﹤0.01% | 1322 |
|
|
2018
Q2 | $43K | Hold |
479
| – | – | ﹤0.01% | 1359 |
|
|
2018
Q1 | $35K | Buy |
479
+359
| +299% | +$24.6K | ﹤0.01% | 1460 |
|
|
2017
Q4 | $7K | Sell |
120
-409
| -77% | -$21.5K | ﹤0.01% | 1916 |
|
|
2017
Q3 | $24K | Buy |
529
+401
| +313% | +$16.7K | ﹤0.01% | 1534 |
|
|
2017
Q2 | $5K | Buy |
+128
| New | +$5.26K | ﹤0.01% | 1901 |
|
|
2017
Q1 | – | Sell |
-34
| Closed | -$1K | – | 2156 |
|
|
2016
Q4 | $1K | Hold |
34
| – | – | ﹤0.01% | 2122 |
|
|
2016
Q3 | $1K | Buy |
+34
| New | +$1.17K | ﹤0.01% | 2152 |
|
|
2016
Q1 | – | Sell |
-142
| Closed | -$5K | – | 2462 |
|
|
2015
Q4 | $5K | Buy |
142
+2
| +1% | +$65 | ﹤0.01% | 2179 |
|
|
2015
Q3 | $5K | Buy |
140
+47
| +51% | +$1.77K | ﹤0.01% | 2287 |
|
|
2015
Q2 | $4K | Buy |
93
+1
| +1% | +$42 | ﹤0.01% | 2360 |
|
|
2015
Q1 | $4K | Buy |
+92
| New | +$3.85K | ﹤0.01% | 2278 |
|
|
2014
Q4 | – | Sell |
-95
| Closed | -$3K | – | 2414 |
|
|
2014
Q3 | $3K | Sell |
95
-214
| -69% | -$7.64K | ﹤0.01% | 2227 |
|
|
2014
Q2 | $11K | Hold |
309
| – | – | ﹤0.01% | 1986 |
|
|
2014
Q1 | $10K | Buy |
309
+5
| +2% | +$191 | ﹤0.01% | 1985 |
|
|
2013
Q4 | $13K | Sell |
304
-938
| -76% | -$38.6K | ﹤0.01% | 1782 |
|
|
2013
Q3 | $50K | Buy |
1,242
+924
| +291% | +$38.8K | ﹤0.01% | 1303 |
|
|
2013
Q2 | $13K | Buy |
+318
| New | +$12.9K | ﹤0.01% | 1723 |
|
Other funds holding HAE
AI
Fifth Third Bancorp's HAE Position: Q2 2026 in Review
Fifth Third Bancorp reduced its Haemonetics (HAE) stake by 6.5% in Q2 2026, selling an estimated $213K and leaving 47,486 shares worth $3.56M. The position accounts for 0.01% of the portfolio, ranked #979.
Fifth Third Bancorp first reported a position in HAE in Q2 2013 and has held it in 48 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Fifth Third Bancorp held 47,486 shares of Haemonetics worth $3.56M as of Q2 2026.
- Fifth Third Bancorp sold 3,318 Haemonetics shares in Q2 2026, an estimated $213K.
- Haemonetics made up 0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #979 holding.
- Fifth Third Bancorp first reported a position in Haemonetics in Q2 2013 and has held it in 48 quarters since.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.